Herceptin 440 mg

Herceptin 440 mg is a medicine authorised by Swissmedic under authorisation number 55065. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 July 1999 and the authorisation is valid without a time limit. ATC code L01FD01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 55065
  • ATC L01FD01
  • Biotechnological medicines
Authorisation data
Authorisation number55065
NameHerceptin 440 mg
Full nameHerceptin 440 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderRoche Pharma (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FD01
First authorisation29 July 1999
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Herceptin 440 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA29 July 1999
2Herceptin 150 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA05 February 2002

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
21 + 1Durchstechflasche(n)L01FD0107.16.1.A
41Durchstechflasche(n)L01FD0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Herceptin 440 mg authorised in Switzerland?

Yes. Herceptin 440 mg is authorised by Swissmedic under authorisation number 55065, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Herceptin 440 mg have?

Herceptin 440 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Herceptin 440 mg?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com